Patent · US Active

Anti-B7-H4 antibodies and immunoconjugates

US11230600B2 · kind B2 · utility

2Cited by

91References

23Claims

0Family size

Assignee

Genentech, Inc. · US

Inventors

Steven Leong · Berkeley, US
Andrew Polson · San Francisco, US
Paul Polakis · Mill Valley, US
Yan Wu · Foster City, US
Wei-Ching Liang · Foster City, US
Ron Firestein · Burlingame, US

Key dates

Filing date	Oct 22, 2018
Grant date	Jan 25, 2022
Priority date	—
Expiry date	Nov 1, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides anti-B7-H4 antibodies and immunoconjugates and methods of using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.